434: Sildenafil citrate therapy for early-onset severe intrauterine growth restriction - 19/08/11
Doi : 10.1016/j.ajog.2010.10.453
Shannon Dwinnell 1, Laura Magee 2, Kenneth Lim 2, Robert Liston 3, Steven Miller 1, Beth Payne 2, Dan Rurak 2, Rebecca Sherlock 1, M. Amanda Skoll 1, Mark Wareing 4, Philip Baker 5, Peter von Dadelszen 2, Andree Gruslin 6, Bruce Carleton 7, Benny Lee 1
1 University of British Columbia, Vancouver, BC
2 University of British Columbia, Child and Family Research Institute, Vancouver, BC
3 University of British Columbia, Child and Family Research Institute, School of Public and Population Health, Vancouver, BC
4 University of Manchester, Maternal and Fetal Health Research Group, Manchester
5 University of Alberta, Edmonton, AB
6 University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON
7 University of British Columbia, School of Public and Population Health; Child and Family Research Institute, Vancouver, BC
Le texte complet de cet article est disponible en PDF.
Plan
© 2011
Mosby, Inc. Tous droits réservés.
Vol 204 - N° 1S
P. S175 - janvier 2011 Retour au numéro
Article précédent
- 433: Vasopressin concentrations in amniotic fluid of the recipient fetus with twin-twin transfusion syndrome
- Sammy Tabbah, Mounira Habli, Stephanie Lang, James Cnota, Erik Michelfelder, Foong Yen Lim, Sundeep Keswani, Ronald Jaekle, Timothy Crombleholme
- 435: Incidence of non-cardiac structural anomalies in twin-twin transfusion syndrome
- Shivani Patel, Linda Randolph, Kurt Benirschke, Arlyn Llanes, Larisa Yedigarova, Ramen Chmait
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?